Marvin L. Woodall
|
Current Position(s)
Chairman and Chief Executive Officer, Thrombolex, Inc. Education and Training Columbia University, Strategic Leadership Course, International Operations Management Harvard University, C-Level Executive Management Course in Leadership University of Oklahoma, Bachelor’s in Business Administration |
For over 50 years, Mr. Woodall has focused on the development of new medical technologies with involvement spanning from prototype to product. With an emphasis on quality-control, he has led teams through a myriad of operations required to succeed in this medical sector. His expertise includes pre-clinical and First-in-Human studies, randomized controlled trials, international regulations, reimbursement, physician training, sales and marketing, and securing high adoption rates while containing cost.
In 1963, Mr. Woodall began his career at Johnson & Johnson Interventional Systems as a medical products sales representative in Houston, where he worked among pioneers in cardiology at the Texas Medical Center. Over 3 decades Mr. Woodall saw increasing responsibility and served as President of multiple companies throughout the world, relocating over 14 times internationally! While serving as President of Johnson & Johnson Interventional Systems Mr. Woodall led the team responsible for the first balloon-expandable stent, followed by the first drug-eluting stent. This development catalyzed numerous analogs, including covered stent grafts for AAA and the more recently transformational TAVR procedure, which is rapid replacement of stenotic aortic valves with a catheter-based delivery of a balloon-expandable stent with leaflets.
Since retiring from Johnson & Johnson in 2001, Mr. Woodall remains dedicated to the clinical art of medical device innovation with several international leadership roles, serving as Chairman, Chief Executive Officer or Board member for several medical device start-up companies and healthcare-oriented nonprofit organizations including Thrombolex, Inc., which is developing a unique catheter with an expandable distal end that can directly deliver thrombolytic drugs to their target: in the center of a major blood clot, such as in cases of pulmonary embolism.
My healthcare experience has also included Chairmanship of a major hospital system in Pennsylvania, serving as the CEO of the Cardiovascular Research Foundation in New York, President of a Free Health Clinic and numerous other Boards of Directors of start-up medical device companies as well as several non-profit healthcare organizations. My wife and I created a charitable foundation fifteen years ago which has provided several million dollars of philanthropic support to worthy organizations.
Mr. Woodall also pursues other passions in his local Eastern Pennsylvania community, leading the revitalization of the Bucks County Playhouse and serving on the Board of the Heritage Conservancy.
Positions and Honors
In 1963, Mr. Woodall began his career at Johnson & Johnson Interventional Systems as a medical products sales representative in Houston, where he worked among pioneers in cardiology at the Texas Medical Center. Over 3 decades Mr. Woodall saw increasing responsibility and served as President of multiple companies throughout the world, relocating over 14 times internationally! While serving as President of Johnson & Johnson Interventional Systems Mr. Woodall led the team responsible for the first balloon-expandable stent, followed by the first drug-eluting stent. This development catalyzed numerous analogs, including covered stent grafts for AAA and the more recently transformational TAVR procedure, which is rapid replacement of stenotic aortic valves with a catheter-based delivery of a balloon-expandable stent with leaflets.
Since retiring from Johnson & Johnson in 2001, Mr. Woodall remains dedicated to the clinical art of medical device innovation with several international leadership roles, serving as Chairman, Chief Executive Officer or Board member for several medical device start-up companies and healthcare-oriented nonprofit organizations including Thrombolex, Inc., which is developing a unique catheter with an expandable distal end that can directly deliver thrombolytic drugs to their target: in the center of a major blood clot, such as in cases of pulmonary embolism.
My healthcare experience has also included Chairmanship of a major hospital system in Pennsylvania, serving as the CEO of the Cardiovascular Research Foundation in New York, President of a Free Health Clinic and numerous other Boards of Directors of start-up medical device companies as well as several non-profit healthcare organizations. My wife and I created a charitable foundation fifteen years ago which has provided several million dollars of philanthropic support to worthy organizations.
Mr. Woodall also pursues other passions in his local Eastern Pennsylvania community, leading the revitalization of the Bucks County Playhouse and serving on the Board of the Heritage Conservancy.
Positions and Honors
- Chairman and Chief. Executive Officer, Thrombolex, Inc., 2016-Present
- Chairman of the Board, Bucks Country Playhouse Artists, 2001-present
- President, Cardiovascular Research Foundation
- Johnson & Johnson Interventional Systems, 1963-2001
- Sales and marketing, Procter & Gamble, 1959-1963
- Medical Device CEO Recognition Awards and Local Philanthropy Awards